Bortezomib, response and retreatment in 1st, 2nd, 3rd and 4th line of treatment in patients with multiple myeloma
2012 (English)In: Haematologica, ISSN 0390-6078, E-ISSN 1592-8721, Vol. 97, no supplement 1, 610-610 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2012. Vol. 97, no supplement 1, 610-610 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:kth:diva-141428OAI: oai:DiVA.org:kth-141428DiVA: diva2:696775
17th congress of European Hematology Association, EHA, June 14-17 2012,Amsterdam,The Netherlands
Qc 201409252014-02-152014-02-152014-09-25Bibliographically approved